Bucking the trend [pharmaceutical products].

This article reports about the time when pharmaceutical companies are outsourcing manufacturing to cut costs, and is expanding its award-winning plant in the UK where it makes some of the biggest healthcare brands. An approach is taken to minimise costs and to maximise performance and get the most out of people-which means investing in them. In a global marketplace where UK factories continue to face pressures of closures and outsourcing overseas, healthcare operation looks set to buck the trend and remain in its historic Hull location. [ABSTRACT FROM AUTHOR]